Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2014
08/12/2014US8802632 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
08/12/2014US8802623 PAR-1 antagonists for use in the treatment or prevention of influenza virus type A infections
08/12/2014US8802618 Controlled modulation of amino acid side chain length of peptide antigens
08/12/2014US8802171 Live organism product
08/12/2014US8802158 Methods of use of probiotic Lactobacilli for companion animals
08/12/2014US8802129 Methods for treating retinopathy with extended therapeutic effect
08/12/2014US8802113 Extracellular matrix cancer vaccine adjuvant
08/12/2014US8802112 Treatment and prevention of Gardnerella vaginalis infections
08/12/2014US8802111 Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant
08/12/2014US8802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
08/12/2014US8802106 Peptide compositions and methods for inhibiting herpesvirus infection
08/12/2014US8802105 Antibacterial compositions
08/12/2014US8802104 Parathyroid hormone receptor activation and stem and progenitor cell expansion
08/12/2014US8802103 Compositions and methods for diagnosing and treating cancer
08/12/2014US8802102 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802101 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802100 Formulation of human antibodies for treating TNF-alpha associated disorders
08/12/2014US8802099 Methods to treat allergic conditions
08/12/2014US8802098 Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide
08/12/2014US8802097 Anti-RSPO1 antibodies
08/12/2014US8802096 Anti-C5a binding antibodies with high block activity
08/12/2014US8802095 Injectable, non-aqueous suspension with high concentration of therapeutic agent
08/12/2014US8802094 Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody
08/12/2014US8802093 HER2/neu-specific antibodies and methods of using same
08/12/2014US8802092 Mesothelioma therapeutic agent
08/12/2014US8802090 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
08/12/2014US8802089 Monoclonal antibodies against CD32B
08/12/2014US8802076 Compositions and methods for modulating an immune response
08/12/2014US8802056 Method for testing and treating delayed food allergies
08/12/2014US8800906 Use of transforming growth factor-beta neutralizing antibodies and fusion proteins thereof in treating pain
08/12/2014CA2776927C Phosphorylcholine conjugates and corresponding antibodies
08/12/2014CA2647450C Process for producing a staphylococcal conjugate
08/12/2014CA2607663C Compositions and methods for increasing the stability of antibodies
08/12/2014CA2571565C Dimensional analysis of saccharide conjugates with gpc & sec-mals
08/12/2014CA2558685C Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle
08/12/2014CA2551813C Compositions and methods for the treatment of tumor of hematopoietic origin
08/12/2014CA2542327C Combination therapy for cancer
08/12/2014CA2528053C Phl p 5a derivatives having reduced allergenicity and retained t-cell reactivity
08/12/2014CA2520392C Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding
08/12/2014CA2501422C Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
08/12/2014CA2497644C Whole bacterial cells as immune modulator
08/07/2014WO2014121302A2 Compositions and methods
08/07/2014WO2014121298A2 Methods of populating a gastrointestinal tract
08/07/2014WO2014121132A1 Immunogenic compositions comprising silicified virus and methods of use
08/07/2014WO2014121096A1 New modified live flavobacterium strains, stabilized vaccines comprising same, and methods of making and use thereof
08/07/2014WO2014121085A1 Pd-l1 and pd-l2-based fusion proteins and uses thereof
08/07/2014WO2014121045A1 Colostrum composition enriched in anti-endotoxin antibodies
08/07/2014WO2014121020A2 Treatment of psoriasis using helminthic parasite preparations
08/07/2014WO2014120941A1 Tumor vaccines and methods of use thereof
08/07/2014WO2014120804A1 Enteric coated nanoparticles for oral vaccine and drug delivery and methods of production and use thereof
08/07/2014WO2014120642A1 Diagnosis and treatment of hepatorenal syndrome
08/07/2014WO2014120569A1 Methods and compositions for human epididymis protein-4 (he4)
08/07/2014WO2014120555A1 Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
08/07/2014WO2014118705A1 Methods of treating chronic kidney disease-mineral and bone disorder using sclerostin antagonists
08/07/2014WO2014118550A1 Biomarkers of autoimmune and/or chronic diseases associated with joint inflammation
08/07/2014WO2014118385A1 The use of dna sequences encoding an interferon as vaccine adjuvants
08/07/2014WO2014118305A1 Intradermal delivery of immunological compositions comprising toll-like receptor agonists
08/07/2014WO2014118201A1 Multivalent glycoconjugate vaccines
08/07/2014WO2014117272A1 Spermidine/spermine n1-acetyltransferase antibodies as anti-cancer drug compounds
08/07/2014WO2014117220A1 Anti-cd83 antibodies and use thereof
08/07/2014WO2014052378A8 Subunit immersion vaccines for fish
08/07/2014WO2013119716A8 Compositions and methods for using csf1r inhibitors
08/07/2014WO2013063062A3 Il-19 as a biomarker of tslp treatment
08/07/2014US20140221621 Single-chain multivalent binding protein compositions and methods
08/07/2014US20140220600 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
08/07/2014US20140220133 Nanotechnology Based Medicine for Biodefense
08/07/2014US20140220117 Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of Cancer
08/07/2014US20140220108 Cochleate compositions and methods of making and using same
08/07/2014US20140220105 Tape preparation of wt1 peptide cancer vaccine for transdermal administration
08/07/2014US20140220100 Vaccine composition for transdermal administration
08/07/2014US20140220079 Vaccine composition for mucosal administration
08/07/2014US20140220077 New Modified Live Flavobacterium Strains, Stabilized Vaccines Comprising Same, and Methods of Making and Use Thereof
08/07/2014US20140220076 Recombinant Mistletoe Lectin and use Thereof as an Adjuvant
08/07/2014US20140220075 Multi plasmid system for the production of influenza virus
08/07/2014US20140220074 Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response
08/07/2014US20140220073 Immunization Compositions and Methods
08/07/2014US20140220067 Live attenuated chimeric porcine circovirus vaccine
08/07/2014US20140220066 Group a streptococcus multivalent vaccine
08/07/2014US20140220065 Therapeutic application of s. pyogenes c-terminal peptide
08/07/2014US20140220064 Immunizing composition
08/07/2014US20140220063 Vaccine composition
08/07/2014US20140220060 Hiv-1 south african subtype c env proteins
08/07/2014US20140220059 Wt1 peptide cancer vaccine composition for mucosal administration
08/07/2014US20140220058 Vaccine composition for transdermal or mucosal administration
08/07/2014US20140220057 Wt1 peptide cancer vaccine composition for transdermal administration
08/07/2014US20140220056 Vaccine composition for transdermal administration
08/07/2014US20140220055 Wt1 peptide cancer vaccine composition for transdermal administration
08/07/2014US20140220054 Wt1 hla class ii-binding peptides and compositions and methods comprising same
08/07/2014US20140220051 Methods of modulating hvem, btla and cd160 cis complex response or signaling activity with soluble light polypeptide sequences
08/07/2014US20140220047 Monomethylvaline compounds capable of conjugation to ligands
08/07/2014US20140220045 Compositions of a Peptide Targeting System for Treating Cancer
08/07/2014US20140220044 Method for the production of hydrolyzed allergens
08/07/2014US20140220041 Compounds for use in the treatment of alzheimer's disease
08/07/2014US20140220036 Methods for treating neurodegenerative diseases and for identifying agents useful for treating neurodegenerative diseases
08/07/2014US20140220033 Administration of an Anti-Activin-A Compound to a Subject
08/07/2014US20140220029 Combined use of a modulator of cd3 and a glp-1 compound
08/07/2014US20140220025 Novel stip1 polypeptides and uses thereof
08/07/2014US20140220024 Chymase compositions, antibodies, diagnostics, and therapeutic methods related thereto
08/07/2014US20140220023 Method of treating osteoarthritis with an antibody to ngf
08/07/2014US20140220020 Il-1 binding proteins
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 1823